false UT 0001946573 0001946573 2025-09-15 2025-09-15 0001946573 NAKA:CommonStockParValue0.001Member 2025-09-15 2025-09-15 0001946573 NAKA:TradeableWarrantsToPurchaseSharesOfCommonStockParValue0.001PerShareMember 2025-09-15 2025-09-15 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.

 

FORM 8-K

 

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): September 15, 2025

 

Kindly MD, Inc.

(Exact name of registrant as specified in its charter)

 

001-42103   84-3829824
(Commission File Number)   (IRS Employer Identification Number)
     
5097 South 900 East, Suite 100, Salt Lake City, UT   84117
(Address of Principal Executive Offices)   (Zip Code)

 

(385) 388-8220

(Registrant’s telephone number, including area code)

 

N/A
(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Each Class   Trading Symbol(s)   Name of Each Exchange on Which Registered
Common Stock, par value $0.001   NAKA   The Nasdaq Stock Market LLC
Tradeable Warrants to purchase shares of Common Stock, par value $0.001 per share   NAKAW   OTC Pink Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

 

 

Item 7.01 Regulation FD Disclosure.

 

On September 15, 2025, Kindly MD, Inc., a Utah corporation (the “Company”) published a letter to its shareholders explaining that it had filed a Form S-3 on September 12, 2025. The letter noted that the Company expects share price volatility to increase for a period of time but emphasized its commitment to its long-term vision. A copy of the letter is furnished hereto as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated into this Item 7.01 by reference.

 

The information furnished pursuant to this Item 7.01, including Exhibit 99.1, will not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and will not be incorporated by reference into any filing under the Securities Act of 1933, as amended, unless specifically identified therein as being incorporated therein by reference. 

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits.

 

Exhibit No.   Description of Exhibit
99.1   Letter to Shareholders, dated September 15, 2025
104   The cover page from this Current Report on Form 8-K, formatted in Inline XBRL.

 

1

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunder duly authorized.

 

  KINDLY MD, INC.
     
Dated: September 15, 2025 By: /s/ David Bailey
    David Bailey
    Chief Executive Officer

 

 

2

 

 

Exhibit 99.1

 

 

David Bailey, Chairman and CEO of KindlyMD

SEPTEMBER 15, 2025

 

 

To our shareholders:

 

From the moment Kindly MD, Inc. announced its intention to merge with Nakamoto Holdings, Inc., through last month’s closing, and into today, our stock has experienced extreme volatility, both up and down. Your support and investment reflect the trust you’ve placed in our leadership and vision. That trust is the foundation on which we are building, and we are committed to earning it every day.

 

The entire public Bitcoin treasury space has been tested in recent months, yet this is exactly when conviction matters most. The question is not whether challenges exist—they always do—but whether the principles that guide us remain intact.

 

After more than 13 years of building through Bitcoin’s cycles, including four bear markets with 70%+ drawdowns, we know resilience and discipline separate those who endure from those who fade. Our core principles have not changed. We believe in Bitcoin’s long-term strength as the global reserve asset, and we believe that its growth trajectory through public markets is inevitable for global adoption. That moment has arrived, and we believe our unmatched experience in Bitcoin, our commitment to this vision and our strategy to build an enduring legacy for this industry, is a unique strength that will make our company and its shareholders a tour de force in the next adoption cycle. 

 

In addition, KindlyMD’s health care subsidiary is positioned at the forefront of a personalized healthcare landscape, leveraging advanced data analytics and integrated treatment protocols to deliver a more holistic and meaningful patient experience.

 

We are more than just a healthcare company with a Bitcoin treasury. Our mission is to build the defining Bitcoin-native financial institution. Our mission is to build the defining Bitcoin-native financial institution. 

 

Our S3 Filing and PIPE Share Registration

 

On Friday, September 12th, we filed Form S3, registering the shares sold in our PIPE fundraising. With these shares entering the market, we expect share price volatility may increase for a period of time. However, we view this moment as a critical opportunity for us to establish our base of aligned shareholders who are committed to our long-term vision. The foundation we build over the next few weeks and months will propel our strategy forward, for those that want to be part of it. For those shareholders who have come looking for a trade, I encourage you to exit. This transition may represent a point of uncertainty for investors, and we look forward to emerging on the other side with alignment and conviction amongst our backers. We’ve been working hard to prepare for what’s next, we have a plan, and we are prepared.

 

 

 

 

 

Our Thesis

 

Bitcoin has moved firmly into the mainstream of finance. What was once dismissed as a fringe experiment has become a trillion-dollar asset, held by institutions, sovereigns, public companies, and millions of individuals worldwide. We believe every class of investor, across every major capital market, will recognize the need for exposure. Yet unlike any other mainstream asset, whether equities, bonds, or commodities, direct ownership of Bitcoin remains uniquely difficult across the globe. 

 

We believe this has created an unprecedented opportunity for new Bitcoin investors and for the longstanding Bitcoin industry. The securities of publicly-traded Bitcoin treasury companies provide investors with Bitcoin exposure, conform with existing regulatory frameworks, and are accessible through the same brokerage accounts investors already use. We expect the rise of Bitcoin treasury companies to dramatically expand access to Bitcoin and diversify the global investor landscape. In turn, we expect this will increase liquidity in Bitcoin and grow value for our shareholders.

 

 

Our Bitcoin Strategy 

 

Raise capital to build a Bitcoin-denominated treasury

 

Invest our Bitcoin into Bitcoin-focused companies or companies with Bitcoin on the balance sheet (i.e., Bitcoin-backed securities) across markets and asset classes

 

Earn Bitcoin-linked income by building a portfolio of Bitcoin-native operating companies

 

Compound Bitcoin per share and repeat

 

In short: Grow. Invest. Earn. Save. These are the fundamentals of building any enduring enterprise. The difference is that our company is being built on a Bitcoin standard.

 

 

Our Execution

 

Since inception of our Bitcoin strategy, we have:

 

Raised $742 million and completed our merger

 

Established a 5,700+ BTC treasury

 

Built a seasoned leadership team

 

Launched a $5 billion ATM program in partnership with eight leading financial institutions, including TD Securities

 

Closed our first investment into Dutch Bitcoin treasury company, Treasury, alongside Winklevoss Capital

 

Committed $30M investment into Metaplanet, Japan’s leading Bitcoin treasury company

 

2

 

 

 

Secured an option to acquire BTC Inc, owner of Bitcoin Magazine, The Bitcoin Conference, subject to its acquisition of UTXO Management 

 

Launched our options chain with Nasdaq

 

Streamlined healthcare operations in Utah, dramatically improving per-patient, per-visit profit metrics

 

Beyond these milestones, the leadership team we’ve assembled has a proven track record of building iconic, enduring, and profitable companies, including at Foundry, Galaxy, Fidelity Investments, Bitcoin Magazine, UTXO Management, The Bitcoin Conference, and VICE Media. This track record demonstrates not only operational excellence, but the ability to transform bold ideas into enduring institutions.

 

 

Looking Ahead

 

Our mission is clear: build the leading Bitcoin-native financial institution. That requires a long-term strategy, creative thinking, and disciplined yet nimble execution. What I’ve shared today is a summary of our strategy and what we’ve accomplished in our first 30 days. 

 

We are confident that the combination of a strong treasury, strong leadership, a proven track record, and an ambitious vision, we are positioned to lead this emerging category. We will continue to pursue growth responsibly, compound Bitcoin per share, and above all, steward your trust.

 

Thank you for standing with us at the start of this journey. I hope that you share our conviction and join us in this exciting next chapter.

 

3